SV2C and Parkinson disease: While these findings have yet to be replicated in independent studies, such insights may suggest that SV2C genetic variants could play a critical role in tailoring PD management strategies, offering a framework for the stratification of PD subtypes and the selection of individualized therapeutic options that maximize efficacy and minimize adverse effects.